[1] Amin M B,Crotty T B,Tickoo S K,et al. Renal oncocytoma:a reappraisal of morphologic features with clinicopathologic findings in 80 cases[J]. Am J Surg Pathol,1997,21(1):1
[2] 孔晓静,王海屹,叶慧义. CT动态增强扫描鉴别肾嫌色细胞癌与肾嗜酸细胞瘤的价值[J].中国医学影像学杂志,2013,21(10):761
[3] Moch H,Cubilla A L,Humphrey P A,et al. The 2016 WHO classification of tumours of the urinary system and male genital organs-part A:renal,penile,and testicular tumours[J]. Eur Urol,2016,70(1):93
[4] Ljungberg B,Bensalah K,Canfield S,et al. EAU guidelines on renal cell carcinoma:2014 update[J]. Eur Urol,2015,67(5):913
[5] Ishigami K,Jones A R,Dahmoush L,et al. Imaging spectrum of renal oncocytomas:a pictorial review with pathologic correlation[J]. Insights Imaging,2015,6(1):53
[6] Wobker S E,Przybycin C G,Sircar K,et al. Renal oncocytoma with vascular invasion:a series of 22 cases[J]. Hum Pathol,2016,58(58):1
[7] Pedrosa I,Sun M R,Spencer M,et al.MR imaging of renal masses: correlation with findings at surgery and pathologic analysis[J]. Radiographics,2008,28(4):985
[8] Goyal A,Sharma R,Bhalla A S,et al. Diffusion-weighted MRI in renal cell carcinoma: a surrogate marker for predicting nuclear grade and histological subtype[J]. Acta Radiol,2012,53(3):349
[9] Vargas H A,Chaim J,Lefkowitz R A,et al. Renal cortical tumors: use of multiphasic contrast-enhanced MR imaging to differentiate benign and malignant histologic subtypes[J]. Radiology,2012,264(3):779
[10] Sun M R,Ngo L,Genega E M,et al. Renal cell carcinoma: dynamic contrast-enhanced MR imaging for differentiation of tumor subtypes--correlation with pathologic findings[J].Radiology,2009,250(3):793
[11] Koh D M,Collins D J. Diffusion-weighted MRI in the body: applications and challenges in oncology[J]. AJR Am J Roentgenol,2007, 188(6):1622
[12] Padhani A R,Liu G,Koh D M,et al.Diffusion-weighted magnetic resonance imaging as a cancer biomarker: consensus and recommendations[J]. Neoplasia,2009,11(2):102
[13] Lassel E A,Rao R,Schwenke C,et al. Diffusion-weighted imaging of focal renal lesions: a meta-analysis[J]. Eur Radiol,2014,24(1):241
[14] Taouli B,Thakur R K,Mannelli L,et al. Renal lesions: characterization with diffusion-weighted imaging versus contrast-enhanced MR imaging[J]. Radiology,2009,251(2):398
[15] Razek A A,Farouk A,Mousa A,et al. Role of diffusion-weighted magnetic resonance imaging in characterization of renal tumors[J]. J Comput Assist Tomogr,2011,35(3):332
[16] G?觟ya C,Hamidi C,Bozkurt Y,et al. The role of apparent diffusion coefficient quantification in differentiating benign and malignant renal masses by 3 tesla magnetic resonance imaging[J]. Balkan Med J,2015,32(3):273
[17] Lei Y,Wang H,Li H F,et al. Diagnostic significance of diffusion-weighted MRI in renal cancer[J]. Biomed Res Int,2015:172165
[18] Sandrasegaran K,Sundaram C P,Ramaswamy R,et al. Usefulness of diffusion-weighted imaging in the evaluation of renal masses[J]. Am J Roentgenol,2010,194(2):438
[19] LeBihan D. Intravoxel incoherent motion imaging using steady-state free precession[J]. Magn Reson Med,1988,7(3):346
[20] Zhong Y,Wang H,Shen Y,et al. Diffusion-weighted imaging versus contrast-enhanced MR imaging for the differentiation of renal oncocytomas and chromophobe renal cell carcinomas[J]. Eur Radiol,2017,27(12):4913
[21] Sevcenco S,Heinz-Peer G,Ponhold L,et al. Utility and limitations of 3-Tesla diffusion-weighted magnetic resonance imaging for differentiation of renal tumors[J]. Eur J Radiol,2014,83(6):909
[22] Mirka H,Korcakova E,Kastner J,et al. Diffusion-weighted imaging using 3.0 T MRI as a possible biomarker of renal tumors[J]. Anticancer Res,2015,35(4):2351
[1]王 奇,张昌文,张志宏.肾上腺皮质嗜酸细胞瘤1例报告[J].天津医科大学学报,2018,24(01):23.